These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 10463867)

  • 21. Risk factors for developing avascular filtering bleb after fornix-based trabeculectomy with mitomycin C.
    Hirooka K; Mizote M; Baba T; Takagishi M; Shiraga F
    J Glaucoma; 2009; 18(4):301-4. PubMed ID: 19365195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glaucoma-filtering bleb infections.
    Mac I; Soltau JB
    Curr Opin Ophthalmol; 2003 Apr; 14(2):91-4. PubMed ID: 12698049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 5-year incidence of bleb-related infection and its risk factors after filtering surgeries with adjunctive mitomycin C: collaborative bleb-related infection incidence and treatment study 2.
    Yamamoto T; Sawada A; Mayama C; Araie M; Ohkubo S; Sugiyama K; Kuwayama Y;
    Ophthalmology; 2014 May; 121(5):1001-6. PubMed ID: 24424248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of intraoperative 5-fluorouracil or lower dose mitomycin-C administration on initial trabeculectomy surgery.
    Smith MF; Doyle JW; Nguyen QH; Sherwood MB
    J Glaucoma; 1997 Apr; 6(2):104-10. PubMed ID: 9098818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of intraoperative 5-fluorouracil or mitomycin C on glaucoma filtration surgery in the rabbit.
    Khaw PT; Doyle JW; Sherwood MB; Smith MF; McGorray S
    Ophthalmology; 1993 Mar; 100(3):367-72. PubMed ID: 8460007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcomes of needle revision of trabeculectomy blebs with mitomycin C and 5-fluorouracil: a comparative safety and efficacy report.
    Anand N; Khan A
    J Glaucoma; 2009 Sep; 18(7):513-20. PubMed ID: 19223788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Midterm follow-up results of combined phacoemulsification, lens implantation, and mitomycin-C trabeculectomy procedure.
    Belyea DA; Dan JA; Lieberman MF; Stamper RL
    J Glaucoma; 1997 Apr; 6(2):90-8. PubMed ID: 9098816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characteristics and leakage of functioning blebs after trabeculectomy with mitomycin-C in primary glaucoma patients.
    Hu CY; Matsuo H; Tomita G; Suzuki Y; Araie M; Shirato S; Tanaka S
    Ophthalmology; 2003 Feb; 110(2):345-52. PubMed ID: 12578779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late-onset bleb infections: prevalence and risk factors.
    Sharan S; Trope GE; Chipman M; Buys YM
    Can J Ophthalmol; 2009 Jun; 44(3):279-83. PubMed ID: 19491982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for development of post-trabeculectomy endophthalmitis.
    Lehmann OJ; Bunce C; Matheson MM; Maurino V; Khaw PT; Wormald R; Barton K
    Br J Ophthalmol; 2000 Dec; 84(12):1349-53. PubMed ID: 11090471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of mitomycin on filtering blebs. Lack of fibrovascular proliferative response following severe inflammation.
    Yaldo MK; Stamper RL
    Arch Ophthalmol; 1993 Jun; 111(6):824-6. PubMed ID: 8512484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and risk factors of infections after glaucoma filtering surgery.
    Poulsen EJ; Allingham RR
    J Glaucoma; 2000 Dec; 9(6):438-43. PubMed ID: 11131749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery.
    Mandal AK; Bagga H; Nutheti R; Gothwal VK; Nanda AK
    Eye (Lond); 2003 Jan; 17(1):53-62. PubMed ID: 12579171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing trends in the incidence of bleb-related infection in trabeculectomy.
    Rai P; Kotecha A; Kaltsos K; Ruddle JB; Murdoch IE; Bunce C; Barton K
    Br J Ophthalmol; 2012 Jul; 96(7):971-5. PubMed ID: 22334138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bleb-associated endophthalmitis: Proportion, presentation, management and outcomes in Victoria, Australia.
    Kwon HJ; Kumar H; Green CM; Crowston JG; McGuinness MB; Kerr NM
    Clin Exp Ophthalmol; 2019 Jul; 47(5):588-597. PubMed ID: 30788894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late-onset blebitis/endophthalmitis: incidence and outcomes with mitomycin C.
    Muckley ED; Lehrer RA
    Optom Vis Sci; 2004 Jul; 81(7):499-504. PubMed ID: 15252348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The long-term cystic bleb appearance and safety after trabeculectomy with mitomycin C].
    Mizoguchi T; Matsumura M; Kadowaki H; Kuroda S; Terauchi H; Nagata M
    Nippon Ganka Gakkai Zasshi; 1997 Nov; 101(11):874-8. PubMed ID: 9396234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitomycin C and 5-fluorouracil antimetabolite therapy for pediatric glaucoma filtration surgery.
    Snir M; Lusky M; Shalev B; Gaton D; Weinberger D
    Ophthalmic Surg Lasers; 2000; 31(1):31-7. PubMed ID: 10976558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Encapsulated filtering blebs--incidence and methods of treatment].
    Ignjatović Z; Misailović K; Kuljaca Z
    Srp Arh Celok Lek; 2001; 129(11-12):296-9. PubMed ID: 11928614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short term experience with "modern" trabeculectomy augmented with intraoperative antimetabolites.
    Detry-Morel M; Pourjavan S
    Bull Soc Belge Ophtalmol; 2005; (296):37-48. PubMed ID: 16050418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.